hVIVO CEO, Kym Denny, announced as an honouree in the 2017 PharmaVOICE 100
Kym Denny, CEO at hVIVO plc, has been announced as an honouree in the 2017 PharmaVOICE 100 to celebrate the leaders throughout the life-sciences industry who provide inspiration to their peers, colleagues, and companies through their innovative and motivational approaches to addressing the industry’s myriad challenges.
Kym Denny defines leadership as helping others through periods of change and ambiguity. She commented: “The essential characteristic of leadership is defining a path forward when there isn’t one, to rally the organization around the ultimate goal, and getting the teams excited to embrace that goal as their own. It’s essential to make the change relevant and paint the vision, bringing the rest of the organization/team with you and celebrating successes along the way.”
To view Kym’s profile within the ‘Commanders & Chiefs’ section of the PharmaVOICE 100, please click on link below:
About PharmaVOICE 100
Each year, the July/August issue of PharmaVOICE magazine celebrates 100 honourees through the print and digital editions.
The PharmaVOICE 100 recognizes the most inspiring people in the life-sciences industry, as determined by the magazine’s readers.
The PharmaVOICE 100 are leaders in research and development, marketing, technology, creativity, strategy, medicine, etc. They positively impact their peers, their colleagues, their companies, their communities, as well as the industry at large through their actions.
The PharmaVOICE 100 set industry trends, their passion and conviction create opportunities out of obstacles. They are innovative and have the ability to think outside-the-box. They develop breakthrough strategies, products, and services. They are known for pioneering new paths and lifting their companies to new heights. They also take the time to mentor the next generation of industry leaders.